Comparison of dextranomer hyaluronic acid copolymer and polyacrylate polyalcohol copolymer for subureteric injection in children with primary vesicoureteral reflux
A retrospective study of 45 children with primary vesicoureteral reflux found that dextranomer hyaluronic acid copolymer (Dx/HA) and polyacrylate polyalcohol copolymer (PPC) achieve comparable success rates in treating the condition, with efficacy for both agents declining as the reflux grade increases.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the delicate landscape of a child's urinary system, a condition known as vesicoureteral reflux can turn a simple flow of urine into a dangerous loop. Normally, a one-way valve at the junction where the ureter meets the bladder prevents urine from backing up toward the kidneys. When this valve fails, urine can travel backward, carrying bacteria that cause infections and potentially leading to permanent scarring of the kidney tissue. For decades, fixing this defect required open surgery, a significant procedure involving a large incision and a lengthy recovery. In recent years, however, doctors have turned to a less invasive approach: a subureteric injection. This technique involves threading a tiny camera into the bladder and injecting a small amount of gel-like material just beneath the opening of the ureter. The goal is to build a small mound that acts as a cushion, plugging the gap and restoring the one-way flow without the trauma of open surgery.
The medical community has long relied on two specific types of materials for this injection, each with its own characteristics. One is a mixture of dextranomer and hyaluronic acid, a substance that the body eventually absorbs over time. The other is a polyacrylate polyalcohol copolymer, a material designed to remain in place permanently, surrounded by a protective layer of scar tissue that forms around it. While both have been used successfully, a lingering question remained: does the fact that one material disappears while the other stays put make a real difference in how well the treatment works for children?
To answer this, researchers at a single medical center in Turkey reviewed the records of 45 children treated between 2002 and 2017. These children, ranging in age and severity of their condition, had a total of 55 kidneys affected by the reflux. The doctors did not randomly assign the children to receive one material or the other; instead, the choice depended on which material was available at the time and the preference of the surgeon performing the procedure. The team carefully tracked the outcomes, checking the children's bladders with a special X-ray test at three months and again at one year after the injection. They defined success as the complete disappearance of the backward flow of urine, while any remaining flow, even if it was less severe than before, was considered a failure of that specific attempt.
The results of this comparison were striking in their simplicity. When looking at the children who received the dextranomer and hyaluronic acid mixture, 72 percent of their kidneys were cured after the first injection. For the children treated with the permanent polyacrylate polyalcohol copolymer, the success rate was nearly identical at 70 percent. When the researchers looked at the children who needed a second injection because the first attempt did not fully work, the final success rates remained very close: 88 percent for the first group and 83 percent for the second. Statistical analysis showed that these small differences were not significant, suggesting that the two materials perform with comparable effectiveness.
The study also revealed that the severity of the condition mattered far more than the type of material used. In cases where the reflux was mild or moderate, both materials achieved a perfect cure rate of 100 percent after a single injection. However, as the severity of the reflux increased, the success rates for both materials dropped. For the most severe cases, the success rate fell to around 60 percent, regardless of whether the temporary or the permanent material was used. This finding indicates that the difficulty of the repair is dictated by the anatomy of the child's own body rather than the specific brand of gel chosen by the surgeon.
Ultimately, the research suggests that the fear that a temporary material might lose its effectiveness as it is absorbed by the body was unfounded within the first year of treatment. Both the absorbable and the non-absorbable agents provided similar protection against the backward flow of urine. The study concludes that for pediatric urologists, the choice between these two materials can be made based on availability or personal preference, as both offer a safe and effective alternative to open surgery, particularly for children with less severe forms of the condition. The true challenge in achieving a cure lies not in the material itself, but in the complexity of the individual case.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.